Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response (2025) Atreya R, Neurath M Journal article, Editorial Update zur Pathophysiologie, Prädiktion und Prävention chronisch-entzündlicher Darmerkrankungen (2025) Fischer S, Neurath M Journal article Risk factors associated with complications of palliative drainage of ascites with tunneled peritoneal catheters (2025) Machnik D, Fischer S, Vetter M, Lamprecht-Bailer R, Rouse-Merkel R, Klett D, Neurath M, et al. Journal article Guided Multispectral Optoacoustic Tomography for 3D Imaging of the Murine Colon (2025) Knieling F, Brown EL, Eckstein M, Thoma OM, Wachter F, Mandelbaum H, Ludwig P, et al. Journal article Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseases. (2025) Yalcin-Mutlu M, Kleyer A, Krönke G, Fagni F, Temiz SA, Meder C, Dietrich P, et al. Journal article Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial. (2025) Plechschmidt J, Fietkau K, Hepp T, Dietrich P, Fischer S, Krebs S, Neurath M, et al. Journal article IBUS-SAS Is a Highly Accurate Intestinal Ultrasound Score for Predicting Endoscopic Disease Activity in Ulcerative Colitis (2025) Fischer S, Fischmann D, Wilde J, Vetter M, Wolf L, Geppert CI, Atreya R, et al. Journal article Intestinal epithelial Gasdermin C is induced by IL-4R/STAT6 signaling but is dispensable for gut immune homeostasis (2024) Gámez Belmonte MdlR, Wagner Y, Mahapatro M, Wang R, Erkert L, Gonzalez Acera M, Cineus R, et al. Journal article, Original article Linking IL-10 signaling with lipid metabolic programs in macrophages: dysregulated ceramide homeostasis drives colitis (2024) Atreya I, Neurath M Journal article Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study (2024) Suzuki K, Sameshima Y, Yokoyama J, Terai S, Yoneyama H, Atreya R, Neurath M, et al. Journal article